'Joyous' woman dies from brain tumour after taking contraceptive injection

AI Article: Perplexity Google Lens
Kim Lewis loved butterflies – at home, they’ve multiplied in her absence.

They decorate the garden where the urn containing her ashes rests, as well as the skin of her parents Tricia and Alan, who each have commemorative tattoos.

Kim died in December 2023, just eight days after being diagnosed with an inoperable brain tumour.

Now, her mother Tricia is among hundreds of women in the UK seeking legal advice after learning there may be a link between the contraceptive injection Kim had been given for years and the tumour that killed her.

We cannot know for certain whether Depo-Provera caused the brain tumor; but Tricia fears that without it Kim would still be here.

Tricia was one of the dozens of people who contacted ITV News following our previous report on the issue; many more responded with their own experiences online.

Depo-Provera's UK manufacturer Pfizer said: "Patient safety is our top priority. We conduct rigorous and continuous monitoring of all our medicines, including assessments of reported adverse events, in collaboration with health authorities around the globe.

"Depo-Provera (medroxyprogesterone acetate) has been approved in more than 60 countries over the last 30 years, has a well-established efficacy and safety profile and has been a treatment option for millions of patients during that time.

"People should talk to their doctor, pharmacist or nurse if they have any concerns or experience any side effects."

Dr Alison Cave, MHRA Chief Safety Officer, said: "Patient safety is our top priority. MHRA continuously monitors all licensed medicines for safety.
"Depo-Provera is an injectable contraceptive injection, which contains medroxyprogesterone acetate (MPA) and is used to prevent unwanted pregnancy.

"Product information for products containing MPA was initially updated in 2024 following studies which showed a risk of meningioma associated with use of high dose MPA. It was further updated in early 2025 with new advice and additional measures to manage the risk. The Patient Information Leaflet was also updated to ensure patients were aware of the symptoms of meningioma and with the advice that they should contact their doctor if they experienced these symptoms.

"For the majority of people, the benefits of Depo-Provera far outweigh the risk, but we advise anyone with any concerns to speak with their GP, pharmacist or contraceptive provider."

• Subscribe to ITV News on YouTube: http://bit.ly/2lOHmNj
• Get breaking news and more stories at http://www.itv.com/news

Follow ITV News on TikTok https://www.tiktok.com/@itvnews?lang=en
Follow ITV News on Instagram: https://www.instagram.com/itvnews/
Follow ITV News on Facebook: https://www.facebook.com/itvnews/
Follow ITV News on X: https://twitter.com/itvnews
Posted by Fast News in Default Category 45 minutes ago  ·  Public

Comments (0)

New Videos

AI Article